NCT02024607 A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02023710 Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma Status UNKNOWN Phase PHASE2
NCT02022917 Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02020707 Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers Status COMPLETED Phase PHASE1
NCT02017717 A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients Status COMPLETED Phase PHASE3
NCT02015351 Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study Status COMPLETED Phase NA
NCT02005120 Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC Status UNKNOWN Phase PHASE2
NCT01999270 Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors Status COMPLETED Phase PHASE1
NCT01996306 A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC Status COMPLETED Phase PHASE3
NCT01995188 A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01989780 Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer Status COMPLETED Phase PHASE2
NCT01984242 A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT01969708 Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Status COMPLETED Phase PHASE3
NCT01966913 Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT01966003 Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01959490 Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer Status COMPLETED Phase PHASE2
NCT01950390 Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT01946529 Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2